Plotkin's Vaccines

Inbunden, Engelska, 2023

Av Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin, USA) Orenstein, Walter A. (Professor of Medicine and Pediatrics, and Global Health, Emory University; Associate Director, Emory Vaccine Center, Atlanta GA; Bill & Melinda Gates Foundation, Seattle, WA; Former Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA) Offit, Paul A., MD (Chief, Division of Infectious Diseases, Director, Vaccine Education Center, The Children's Hospital of Philadelphia; Professor of Pediatrics, Maurice R. Hilleman Professor of Vaccinology, Perelman School of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA) Edwards, Kathryn M. (Professor of Pediatrics Emerita

3 959 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

**Selected for Doody’s Core Titles� 2024 with "Essential Purchase" designation in Infectious Disease**

From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field.

Produktinformation

Utgivningsdatum2023-05-05
Mått216 x 276 x 67 mm
Vikt3 870 g
FormatInbunden
SpråkEngelska
Antal sidor1 808
Upplaga8
FörlagElsevier Health Sciences
ISBN9780323790581

Tillhör följande kategorier

Pediatrik inom Medicin
Infektionssjukdomar och smittsamma sjukdomar inom Medicin

SECTION I General Aspects of Vaccination1. A Short History of Vaccination2. Vaccine Immunology3. Non-specific Effects of Vaccines4. Correlates of Protection5. The Vaccine Industry6. Vaccine Manufacturing7. Evolution of Adjuvants Across the Centuries8. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States9. Passive ImmunizationSECTION II Licenced Vaccines and Vaccines in Development10. General Immunization Practices11. Human Adenovirus Vaccines12. Anthrax Vaccines13. Biodefense Vaccines, Vaccines for Emerging Infectious Diseases, and Coalition for Epidemic Preparedness Innovations (CEPI)14. Cancer Vaccines15. Cholera Vaccines16. Combination Vaccines17. Coronavirus Vaccines18. Cytomegalovirus Vaccines19. Dengue Vaccines20. Vaccines Against Diarrhea Caused by Noncholera Bacteria21. Diphtheria Toxoid22. Ebola Vaccines23. Nonpolio Enteroviruses24. Epstein-Barr Virus Vaccines25. Haemophilus Influenzae Type b Vaccines26. Hepatitis A Vaccines27. Hepatitis B Vaccines28. Hepatitis C Vaccines29. Hepatitis E Vaccines30. Herpes Simplex Virus Vaccines31. Human Immunodeficiency Virus Vaccines32. Human Papillomavirus Vaccines33. Inactivated and Recombinant Influenza Vaccines34. Influenza Vaccine-Live35. Japanese Encephalitis Vaccines36. Lyme Disease Vaccines-the Journey Continues37. Malaria Vaccines38. Measles Vaccines39. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines40. Meningococcal Vaccines Directed at Capsular Group B41. Mumps Vaccines42. Noninfectious Disease Vaccines43. Norovirus44. Parasitic Disease Vaccines45. Pertussis Vaccines46. Plague Vaccines47. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines48. Pneumococcal Polysaccharide Vaccines49. Poliovirus Vaccine-Inactivated50. Poliovirus Vaccine-Live51. Lyssaviruses and Rabies Vaccines52. Respiratory Syncytial Virus Vaccines and Monoclonal Antibodies53. Rotavirus Vaccines54. Rubella Vaccines55. Smallpox and Vaccinia56. Staphylococcus aureus Vaccines57. Streptococcus Group A Vaccines58. Streptococcus Group B Vaccines59. Tetanus Toxoid60. Tickborne Encephalitis Vaccines61. Tuberculosis Vaccines62. Typhoid Fever Vaccines63. Varicella Vaccines64. Yellow Fever Vaccine65. Zika Virus Vaccines66. Zoster VaccinesSECTION III New Technologies67. Technologies for Making New Vaccines68. Genetic-Based Vaccine Vectors69. Technologies to Improve ImmunizationSECTION IV Vaccination of Special Groups70. Vaccination of Immunocompromised Hosts71. Vaccines for International Travel72. Vaccines for Healthcare Personnel73. Vaccination of Pregnant WomenSECTION V Public Health and Regulatory Issues74. Immunization in the United States75. Immunization in Europe76. Immunization and Vaccine-Preventable Diseases in the Asia-Pacific Region77. Immunization in Low- and Middle-Income Countries78. Community Protection79. Economic Analyses of Vaccine Policies80. Regulation and Testing of Vaccines in the US81. Regulation of Vaccines in Europe82. Regulation of Vaccines in Low- and Middle-Income Countries83. Vaccine Safety84. Vaccine Hesitancy and Behavioral Factors Associated With Vaccine Uptake85. Legal Issues86. EthicsONLINE ONLY87. Vaccines to Prevent MpoxAPPENDIXWebsites and Applications for Mobile Devices With Information About Immunization

"This book covers the history, immunology, innovative technology, and public health impacts of vaccines, and includes chapters dedicated to each of the commonly used vaccines. Moreover, the title includes a companion ebook that contains late-breaking information on topics such as Mpox, not contained within the print version. This eighth edition is an update to the previous version, published in 2017, which was prior to the widespread use of mRNA vaccines and the SARS-CoV-2 pandemic." -©Doody’s Review Service, 2023, Bradford Becken, MD (University of Nebraska Medical Center) Doody's Score: 5 Stars!